002589 瑞康醫藥
按盤價 
2.900 +0.260 (+9.848%)
2.900 +0.260 (+9.848%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.567 | 0.374 | -28.224 | 1.745 | 3.570 |
| 總資產報酬率 ROA (%) | 0.191 | 0.116 | -8.187 | 0.448 | 0.820 |
| 投入資產回報率 ROIC (%) | 0.246 | 0.149 | -11.048 | 0.655 | 1.257 | 邊際利潤分析 |
| 銷售毛利率 (%) | 12.546 | 10.294 | 13.582 | 18.229 | 18.381 |
| 營業利潤率 (%) | 1.069 | -1.576 | -13.941 | 2.370 | 3.509 |
| 息稅前利潤/營業總收入 (%) | 3.064 | -0.035 | -11.221 | 4.409 | 5.593 |
| 淨利潤/營業總收入 (%) | 1.006 | 0.398 | -14.123 | 1.814 | 2.296 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 85.424 | 152.267 | 17.889 | 109.154 | 102.622 |
| 價值變動淨收益/利潤總額(%) | 80.003 | -132.867 | 52.297 | 44.804 | 15.230 |
| 營業外收支淨額/利潤總額(%) | -7.225 | 6.485 | 1.565 | -7.324 | -4.284 | 償債能力分析 |
| 流動比率 (X) | 1.120 | 1.072 | 1.028 | 1.252 | 1.255 |
| 速動比率 (X) | 1.024 | 0.968 | 0.952 | 1.127 | 1.116 |
| 資產負債率 (%) | 63.793 | 66.264 | 68.627 | 63.279 | 67.281 |
| 帶息債務/全部投入資本 (%) | 55.430 | 57.040 | 62.539 | 58.498 | -- |
| 股東權益/帶息債務 (%) | 79.651 | 74.632 | 59.404 | 69.589 | 55.068 |
| 股東權益/負債合計 (%) | 54.810 | 49.202 | 42.981 | 45.301 | 34.543 |
| 利息保障倍數 (X) | 1.482 | -0.021 | -3.815 | 2.003 | 2.510 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 171.324 | 176.438 | 210.502 | 205.205 | 0.000 |
| 存貨周轉天數 (天) | 52.214 | 51.787 | 51.136 | 52.320 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
